EXAS: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-121,994	-102,400
Depreciation	92,765	61,057
Equity securities, fv-ni, gain (loss)	6,817	-764
Deferred tax expense (benefit)	-512	-1,013
Stock-based compensation	162,024	110,401
Gain on settlement of convertible notes	0	0
Amortization of acquired intangible assets	72,461	48,287
Impairment of long-lived and indefinite-lived assets	6,794	6,251
Gain (loss) on contingent consideration from disposition of asset	0	0
Remeasurement of contingent consideration liabilities	21,901	13,196
Non-cash lease expense	20,248	13,483
Other noncash income (expense)	-8,867	-5,994
Accounts receivable, net	56,233	103,086
Inventory, net	2,356	9,069
Increase (decrease) in operating lease liability	-21,117	-13,841
Accounts payable and accrued liabilities	165,183	98,048
Other assets	-12,194	-4,787
Other liabilities	-13,659	-13,033
Net cash provided by operating activities	339,749	119,826
Purchases of marketable securities	140,269	93,796
Maturities and sales of marketable securities	370,482	330,429
Purchases of property, plant and equipment	103,413	73,516
Payments to acquire intangible assets	0	-
Payments to acquire other investments	51,064	775
Proceeds from contingent consideration receivable	27,971	27,971
Other investing activities	-297	-145
Net cash provided by (used in) investing activities	104,004	190,458
Repayments of convertible debt	249,172	249,172
Payment, tax withholding, share-based payment arrangement	80	-129
Proceeds from stock plans	16,033	16,033
Repayments of accounts receivable securitization	0	0
Proceeds from convertible debt	0	0
Payment for contingent consideration liability, financing activities	19,000	19,000
Other financing activities	-10,158	-8,417
Net cash provided by (used in) financing activities	-262,217	-260,685
Effects of exchange rate changes on cash and cash equivalents	865	864
Net increase (decrease) in cash, cash equivalents and restricted cash	182,401	50,463
Cash and cash equivalents at beginning of period	606,636	-
Cash and cash equivalents at end of period	789,037	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

EXAS: the cashflow